Prof. Cananzi graduated in Medicine and Surgery at the Catholic University in Rome, where he also completed his residency in General Surgery at the “A. Gemelli” University Hospital.
- From 2012 to 2013 he served as clinical fellow to the Upper Gastrointestinal, Hepatobiliary and Pancreatic Surgery Unit at The Royal Marsden Hospital in London (UK).
- In 2013 he joined the IRCCS – Humanitas Research Hospital, serving as surgical oncologist in the Sarcoma, Melanoma and Rare Tumors Surgery Unit.
- In 2018 he was appointed as Assistant Professor of Surgery and in 2023 as Associate Professor of Surgery at Humanitas University.
Associate Professor of General Surgery.
His clinical and translational research activity is focused on surgical oncology especially on retroperitoneal, limb and trunk soft tissue sarcoma, gastrointestinal stromal tumors (GIST) and gastric cancer.
He is author/co-author of more than 130 scientific publications including papers, book chapters and congress abstracts.
He is member of the Connective Tissue Oncology Society (CTOS), European Society of Surgical Oncology (ESSO), Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG), Italian Society of Surgery (SIC), Italian Society of Surgical Oncology (SICO), Italian Sarcoma Group (ISG), and Italian Research Group on Gastric Cancer (GIRCG).
- Ruspi L, Cananzi FCM, Aymerito F, et al. Measuring the impact of complications after surgery for retroperitoneal sarcoma: Is comprehensive complication index better than Clavien-Dindo Classification?. Eur J Surg Oncol. 2022;48(5):978-984
- – Magrini E, Di Marco S, Mapelli SN, et al. Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression. Nat Cancer. 2021;2(2):218-232
- – Cananzi FCM, Ruspi L, Fiore M, Sicoli F, Quagliuolo V, Gronchi A. Major vascular resection in retroperitoneal sarcoma surgery. Surgery. 2021;170(3):848-856
- – Ponzetta A, Carriero R, Carnevale S, et al. Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human Tumors. Cell. 2019;178(2):346-360.e24
- – Cananzi FCM, Ruspi L, Sicoli F, Minerva EM, Quagliuolo V. Did outcomes improve in retroperitoneal sarcoma surgery?. Surg Oncol. 2019;28:96-102
